Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologyCase of Reversible Complete Heart Block

Case of Reversible Complete Heart Block

 

Skin examination was remarkable for multiple diffusely distributed erythematous patches with central clearing, consistent with erythema chronicum migrans.
Skin examination was remarkable for multiple diffusely distributed erythematous patches with central clearing, consistent with erythema chronicum migrans.

 

A previously healthy Caucasian 22-year-old man presented to a southern Quebec community hospital with syncopal episodes for 1 week. He was found to be hypotensive and bradycardic (heart rate 36 beats per minute), owing to third-degree atrioventricular (AV) block, which did not respond to atropine. A perfusion of isoprenaline was started, and the patient was transferred to a tertiary care center in Montreal.

The patient denied any recent travel history outside the province of Quebec. However, the patient frequently visited deeply wooded areas and was in close contact with deer and other wildlife.

On arrival, skin examination was remarkable for multiple diffusely distributed erythematous patches with central clearing, consistent with erythema chronicum migrans (Figure). The remainder of the physical examination was unremarkable.

On the basis of the history and physical examination, a diagnosis of early disseminated Lyme disease with carditis was suspected, and ceftriaxone was started. Screening Lyme serology was positive, and the blood smear was negative for Babesia/Anaplasma spp. The patient’s rash completely resolved within 24 hours of antibiotic initiation.

The transthoracic echocardiogram showed mild nonspecific mitral valve thickening and an ejection fraction of 60%. There were no other echocardiogram abnormalities. After 48 hours of observation, he underwent a temporary VVI (ventricular pacing and sensing mode) pacemaker insertion.

On ceftriaxone, the AV block converted to first degree 2 days after starting antibiotics and then completely resolved by day 11, at which point the pacemaker was removed. He completed a total 21-day course of treatment with oral doxycycline. Western blot testing for Lyme disease was positive, confirming the diagnosis.

To read this article in its entirety please visit our website.

-Samuel De l’Étoile-Morel, MD, Abeer Feteih, MD, Catherine Anne Hogan, MD, MSc, Donald C. Vinh, MD, George Thanassoulis, MD, MSc

This article originally appeared in the August 2017 issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...